Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults
- Resource Type
- Article
- Authors
- Babu, Sunil; Broeders, Nilufer; Lietar, Nicole; Brown, Fiona; Campbell, Philip; Campistol, Josep M.; Chowdhury, Paramit; Kasimatis, Theo; Cirami, Lino; Caroti, Leonardo; Antognoli, Guilia; Delmas, Yahsou; Dobronravov, Vladimir; Gaeckler, Anja; Garrouste, Cyril; Greenwood, Gregory; Griffin, Siân; Huang, Chiu-Ching; Chen, I-Ru; Huang, Susan; Kim, Jin Seok; La Manna, Gaetano; Le Quintrec, Moglie; Jeantet, Guillaume; Fumie, Iino; Rondeau, Eric; Haller, Hermann; Morelle, Johan; Goffin, Eric; Muhlfeld, Anja; Nagaraj, Shashi; Arepally, Gowthami; Oh, Doyeun; Okumi, Masayoshi; Terente, Manuel Praga; Provot, Francois; Schönermarck, Ulf; Fischereder, Michael; Terrada, Natalia Ramos; Seitz-Polski, Barbara; Favre, Guillaume; Boyer-Suavet, Sonia; Vinogradova, Maria; Kirsanova, Tatiana; Wong, Edwin K.S.; Barbour, Thomas; Scully, Marie; Ariceta, Gema; Cataland, Spero; Garlo, Katherine; Heyne, Nils; Luque, Yosu; Menne, Jan; Miyakawa, Yoshitaka; Yoon, Sung-Soo; Kavanagh, David
- Source
- In Kidney International Reports June 2021 6(6):1603-1613
- Subject
- Language
- ISSN
- 2468-0249